Alza Ditropan XL
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The first head-to-head study comparing extended-release Ditropan XL (oxybutynin) and Pharmacia's Detrol (tolterodine) shows incidence of dry mouth was not statistically different for either incontinence drug at the recommended starting doses, investigators report at the 30th Annual Meeting of the International Continence Societ